The Carlyle Group related stories
All articles and analysis
Prudential China fund to invest abroadThe $600m partnership with China's Fosun Group will make public and private investments both domestically and overseas.
- Carlyle hires global real estate IR pro
Alok Gaur, formerly of Credit Suisse Real Estate Private Funds Group and more recently Greenhill & Co, has joined Carlyle in its Washington DC headquarters.
- GIC buys into second Western GP
GIC has reportedly teamed up with Kuwait Investment Authority to buy a 4.5% stake in David Bonderman-led TPG Capital. The sovereign fund bought a stake in Apax in 2009.
- Apollo shows growth in $480m IPO filing
The Leon Black-led firm has $10bn of dry powder for private equity investments and has spent about half of its $14.7bn seventh fund, which closed in 2008.
- Trade sales to dominate Australian exits
Choppy public markets coupled with foreign buyer appetite for Australian assets will help drive M&A activity, according to a recent study.
- Carlyle expands franchise to Africa
After months of speculation and market chatter, Carlyle has confirmed its recruitment of three African private equity specialists including StanChart’s former head of African private equity, Marlon Chigwende, and former Ethos partner Danie Jordaan.
- Carlyle JV to acquire $5bn in shipping assets
Carlyle, alongside a Hong Kong maritime investment firm, will invest $900m in equity over the next five years in the hopes of capturing demand from Chinese state-owned companies.
- Bain, GIC ride off with $852m Indian motorcycle deal
The duo will gain exposure to India's largest motorcycle maker, Hero Honda, having teamed up to finance Hero Investment's $852m acquisition of Honda’s stake in the company.
- Carlyle to open in Peru
The global alternatives group has struck a joint venture agreement with Peruvian financial services heavyweight Credicorp.
- HCA raises $3.79bn in largest-ever PE-backed IPO
KKR- and Bain-backed hospital operator HCA's successful IPO has 'signalled' to the market that private equity-backed healthcare companies could be positioned to thrive under healthcare reform in the US.